Poor countries could be left behind in COVID vaccine distribution

Research​ suggests wealthy countries have secured more than half of the doses from leading vaccines while only representing 14% of the world's population.

• Dec 31, 2020

U.K. authorizes Oxford-AstraZeneca vaccine

The Oxford-AstraZeneca vaccine is easier to distribute than the Moderna or Pfizer vaccines because it requires only basic refrigeration. The newest vaccine could be granted emergency use in the U.S. by April. Charlie D'Agata shares the latest.

• Dec 30, 2020
• 02:01

Official says vaccine rollout is short of goal

The chief scientist for Operation Warp Speed said the government will not meet its goal of vaccinating 20 million Americans by the end of the year. The CDC estimates only 2.6 million people have been vaccinated so far. Manuel Bojorquez reports.

• Dec 30, 2020
• 02:14

U.K. approves Oxford-AstraZeneca vaccine

British regulators have authorized emergency use of the COVID-19 vaccine from Oxford and AstraZeneca, which is cheaper and easier to store than the Pfizer vaccine. This comes a day after a more contagious U.K. variant of the virus was discovered in the U.S. for the first time. CBS News senior foreign correspondent Charlie D'Agata joins CBSN with more.

• Dec 30, 2020
• 05:35

First case of U.K. COVID variant in U.S.

Health officials in Colorado have confirmed the first known case of a more infectious strain of COVID-19 first seen in the U.K. The patient is currently in isolation and he has no travel history. POLITICO health care reporter Dan Diamond joined CBSN's Omar Villafranca to discuss that and more.

• Dec 29, 2020
• 07:47

U.S. struggles with initial vaccine rollout

The CDC says more than 11 million doses of coronavirus vaccines have been shipped across the U.S. this month, but so far only about 2 million people have received the vaccine. Dr Robert Glatter, an emergency physician at Lenox Hill Hospital in New York, joined CBSN to discuss why the U.S. has had a slow start to the rollout of the COVID-19 vaccine. He also talks about a new vaccine formula being tested by Novavax, and his concerns about the hazards of holiday travel amid the pandemic.

• Dec 29, 2020
• 05:02

Hospitals brace for post-holiday COVID surge

More than 2 million Americans have now received a coronavirus vaccine, far less than the 20 million vaccinations promised by the end of the year. The mass vaccination effort continues as thousands of Americans remain hospitalized with the virus. Hospitals are bracing for another surge after millions traveled for the Christmas holiday weekend. Infectious disease specialist Dr. Uzma Syed joins CBSN to discuss the latest.

• Dec 28, 2020
• 10:28

WorldView: Chinese journalist sentenced

The European Union has begun distribution of Pfizer-BioNTech's coronavirus vaccine. Chinese citizen journalist Zhang Zhan has been sentenced to 4 years in prison for her reporting on COVID-19. Extreme weather has cost countries around the globe billions of dollars this past year. CBS News foreign correspondent Ian Lee joins "CBSN AM" with a roundup of today's global headlines.

• Dec 28, 2020
• 04:12

Addressing concerns about COVID vaccines

Public confidence in the coronavirus vaccine appears to be growing, but many people in the U.S. are still unsure if they feel comfortable getting the vaccine, despite its importance in getting the pandemic under control. Professor Gretchen Chapman of Carnegie Mellon University joins CBSN to discuss why a unified message about the vaccine will be so important.

• Dec 27, 2020
• 06:23

Record number of Americans die from COVID in 1 week

Hospitals across the nation are reaching their breaking point as the coronavirus pandemic worsens. For the first time, the U.S. has now reported more than 19,000 deaths from the virus in a single week. CBS News correspondent Lilia Luciano and CBS News chief medical correspondent Dr. Jon LaPook have the latest on the pandemic. Dr. Robert Glatter, an emergency physician at Lenox Hill Hospital in New York City, then joins CBSN's Lana Zak for his take on the health crisis.

• Dec 23, 2020
• 12:54

Dr. Jon LaPook shares his experience getting the COVID vaccine

"Getting the vaccine felt exactly the same to me as getting a flu shot... No big deal." But then the emotional impact of the moment set in.

• Dec 23, 2020

Pfizer to supply U.S. with 100 million more vaccine doses

The $2 billion deal also gives the federal government the option to acquire up to 400 million more doses.

• Dec 23, 2020

U.S. on track to see deadliest year ever

2020 is shaping up to be the deadliest year in U.S. history and it's largely due to the coronavirus pandemic. Cases are skyrocketing nationwide as airports are swarming with holiday travelers. CBS News' Mola Lenghi and Adriana Diaz report on the latest surge and COVID vaccines. Then, Dr. Teresa Amato, director of emergency medicine at Long Island Jewish Forest Hills, joins CBSN's Tom Hanson dives deeper into the vaccine distribution.

• Dec 22, 2020
• 13:26

Concerns over new coronavirus variant

World Health Organization Director-General Tedros Adhanom Ghebreyesus says containing the transmission of the coronavirus is key, in order to prevent the virus from mutating further. New variants of the virus has emerged in several countries, including the U.K. CBS News correspondent Mola Lenghi reports from Newark Liberty International Airport, where travel is ramping up for the holidays, and Dr. Dyan Hes, founder of Gramercy pediatrics, joins CBSN to discuss what scientists are learning so far about the mutation.

• Dec 22, 2020
• 10:45

ICYMI: A look back at Sunday's 60 Minutes

How the Pfizer-BioNTech COVID-19 vaccine was developed; Inside the organization helping prisoners in Africa become lawyers and paralegals; Lalibela, the mysterious holy site

• Dec 21, 2020

Moderna vaccine distribution underway

Vaccine distribution continues nationwide after the FDA authorized the second U.S. vaccine for emergency use. The first Moderna vaccination could happen as early as Monday morning. Correspondent Mola Lenghi reports from Long Island Jewish Medical Center in Queens, New York.

• Dec 21, 2020
• 03:05

How a risky bet on experimental biotechnology led to a COVID-19 vaccine

Bill Whitaker reports on the scientists and advances in biotechnology behind a COVID-19 vaccine that could help end the pandemic.

• Dec 21, 2020

What to expect from Moderna's COVID vaccine

The FDA could authorize emergency use of Moderna's coronavirus vaccine as early as today, which would make it the second vaccine available in U.S. CBS News' David Begnaud reports on the fight against the growing pandemic, and Dr. Annette Reboli, professor of medicine and dean of the Cooper Medical School of Rowan University, join CBSN to discuss the latest on efforts to roll out the vaccines.

• Dec 18, 2020
• 10:01

Health care workers wait for Pfizer vaccine

Health care workers across the country are waiting for their hospital to receive the first round of Pfizer's coronavirus vaccine as COVID-19 surges. Meanwhile, the Food and Drug Administration is gearing up to approve emergency-use authorization for Moderna's vaccine. Dr. Kelechi Olejeme joins CBSN AM one day after receiving the Pfizer vaccine. She explained the differences between the two vaccines and how she felt following her inoculation.

• Dec 18, 2020
• 07:13

FDA set to approve Moderna vaccine

The Food and Drug Administration could approve Moderna's coronavirus vaccine Friday, which means 6 million doses could be shipped around the country as soon as next week. CBS News correspondent David Begnaud and Dr. Bob Lahita, professor at New York Medical College, join CBSN to discuss the nation's worsening crisis and the new vaccine.

• Dec 18, 2020
• 11:30

CDC panel makes recommendation for next Americans to get vaccine

Phase 1B includes Americans 75 and older and frontline workers — including police, firefighters, teachers and grocery workers.

• Dec 20, 2020

COVID vaccine rollout in full swing

The rollout for Pfizer's COVID-19 vaccination is now in full swing. Health care workers across the country were among the first Americans to receive the shot this week. This comes as deaths and cases continue to spike, with the U.S. recording thousands of new deaths each day. "Face the Nation" moderator Margaret Brennan joins CBSN's Lana Zak to discuss that and more.

• Dec 18, 2020
• 09:40

The Atlantic: Next half a year will be "vaccine purgatory"

Many more Americans could soon be vaccinated against the coronavirus as the FDA has given Moderna's vaccine emergency use authorization. Sarah Zhang, a staff writer for The Atlantic, joined CBSN to talk about her reporting, "The Next 6 Months Will Be Vaccine Purgatory."

• Dec 19, 2020
• 06:55

Third allergic reaction to COVID-19 vaccine reported in Alaska

Severe allergic reactions can occur with any vaccine, but are extremely rare.

• Dec 19, 2020

Extra Pfizer vaccine doses bring hope to embattled hospital workers

The discovery means that hundreds more doctors, nurses and support staff like police officers and custodians at Cleveland MetroHealth could get vaccinated early.

• Dec 19, 2020

Show More